K-Startup Networking Day

Join us for an investor event that aims to support IntuitiveX's fundraise and to showcase the promise of five Korean startups.

Over the past four months, through a partnership with the Korean Startup Center (KSC), IntuitiveX alongside University of Washington - CoMotion, Washington Technology Innovation Alliance (WTIA), and Life Science Washington have been providing five Korean companies with strategic guidance, resources and a cohort of mentors to support with their commercialization efforts within the U.S. as they prepare for U.S. market entry.

On December 14, join us for an in-person and virtual showcase where the following five companies — Deep Bio, Olive Healthcare, VNTC, Orange Biomed, and Mezoo  — will share how their novel healthcare technologies are driving innovation to solve unmet challenges in healthcare.

This will be an opportunity for investors to connect directly with IntuitiveX and each of the 5 startups as they continue to scale within the U.S.

_______________________________________

Agenda:

3:30 – 4:00 pm PST: Welcome Reception and SAAM Exhibit Viewing

4:00 – 4:15 pm PST: Opening Ceremony:

• Greeting - KSC/KOSME, Korean Counsul General, Seattle Port Commissioner, and Life Science Washington

4:15 - 4:30 pm PST: Guest Speaker - CEO of WTIA

• Michael Schutzler is the CEO of WTIA, the largest technology association in Washington state. Michael brings over 30 years of experience in the technology industry, launching products and building companies as a product manager, co-founder, and angel investor. In 2013, Herd Freed Hartz placed Michael in his current position and we recently caught up with him to learn more about his philosophy as a leader, WTIA’s mission and his work leading this successful organization over the last several years.

4:30 - 4:40 pm PST: Success Sotry - HRobotics

• Established in 2018, H Robotics is made up of a team of innovators who share a passion for improving lives. We are one of the fastest growing robotics companies that develops, manufactures, and distributes state-of-the-art rehabilitation solutions for people who suffer from neurological and musculoskeletal conditions.

4:40 – 5:55 pm PST: IX & Korean Startup Presentations (5)

• Intro : IX (10 minutes)
• Moderator Introduction
• Presentation : 5 Companies * 7-minute pitch and 5-minute Q&A including feedback per company

5:55 – 6:05 pm PST: Photos

6:05 – 6:35 pm PST: Networking (Rotate to 6 tables)

6:05 – 8:00 pm PST: Dinner, SAAM Exhibit Viewing, & Networking

Co-host: KSC & IX

Partners: UW CoMotion, WTIA, Life Science Washington

_______________________________________

IntuitiveX Recent Progress:

IntuitiveX has recently added the following key advisors and team members to support with the next phase of its growth journey:

Team Members

• Steve Lampkin: Executive Vice President of Commercialization, has 25+ years of medical device sales experience and served as VP of Strategy and Corporate Development at Prosidyan, which recently sold to Johnson & Johnson

Scientific Advisors

• Michael Lim, MD: Chairman and Professor of Neurosurgery at Stanford University
• Deepak Bhatt, MD, MPH: Professor of Cardiovascular Medicine and Executive Director of Interventional Cardiology at Harvard University
• K. Daniel Riew, MD: Chief of Spine Surgery and Professor of Orthopedic Surgery at Columbia University and Chairman of the International Board of AO Spine
• Thomas Mroz, MD: Chairman of the Orthopaedic and Rheumatologic Institute and Director of Clinical Research at the Cleveland Clinic

Business Advisors

• Former Washington Governor Gary Locke: Gary Faye Locke is an American politician and diplomat serving as the interim president of Bellevue College, the largest of the institutions that make up the Washington Community and Technical Colleges system.

Additional Highlights

• Supported launch 12+ portfolio companies inclusive of 3 FDA Breakthrough Device Designated Companies
• Portfolio companies have raised $120M+ in additional funding
• Generated $300M in shareholder value created for portfolio companies
• Built a network of 200+ clinicians
• Fast tracked IP Issuance within 6 - 8 months vs 3 -5 years industry standard
• Own and manage 100+ IP assets across network

_______________________________________

Featured Korean Startups:

Deep Bio

Deep Bio Inc. is an AI healthcare company with in-house expertise in deep learning and cancer pathology. Our vision is to radically improve efficiency and accuracy of pathologic cancer diagnosis and prognosis, by equipping pathologists with deep learning-based IVD SaMDs (In Vitro Diagnostics Software as a Medical Device), for optimal cancer treatment decisions. Deep Bio is actively engaged in the research space and participating in ongoing collaborations with top US medical centers.

Olive Healthcare

Olive Healthcare is a startup developing wellness and medical devices services for the quantitative measurement of body composition, an integral part of the new healthcare paradigm based on prevention. The portable scanner uses near-infrared spectroscopy to measure abdominal fat, a key marker associated with a variety of diseases and a problem area for dieters around the world

VNTC

VNTC is the developor of a device that is effective in suppressing the progression of scoliosis. The startup’s Spinamic brace helps scoliosis patients by correcting posture rather than surgery. Its design helps in correcting the posture of scoliosis patients. Compared to those braces available in the market, Spinamic is fabric-based, lightweight, comfortable, inexpensive, and easier to wear with improved mobility.

Orange Biomed

Orange Biomed is the developer of a medical device designed to measure the level of glycated hemoglobin. The company's point-of-care device offers glycated hemoglobin level results within minutes at the test site and requires a single drop of blood, making it convenient to use, enabling diabetic patients to get their diabetes diagnosed and prevent complications.

Mezoo

Mezoo is the developer of biomedical sensor technology designed to improve human race health by providing accurate diagnoses. The company's technology offer a small-sized, patch-type electrocardiogram that is attached to the test subject's chest and checks in real-time, enabling physicians to manage and prevent heart disease in patients.